LRCX vs. ANAB
LRCX (Lam Research Corporation) and ANAB (AnaptysBio, Inc.) are both stocks. LRCX operates in Semiconductor Equipment & Materials (Technology), while ANAB operates in Biotechnology (Healthcare). Over the past 5 years, LRCX returned 40.10%/yr vs 26.26%/yr for ANAB. At a 0.23 correlation, their price movements are largely independent.
Performance
LRCX vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LRCX achieves a 89.76% return, which is significantly higher than ANAB's 58.91% return.
LRCX
- 1D
- 6.98%
- 1M
- 10.34%
- YTD
- 89.76%
- 6M
- 99.61%
- 1Y
- 278.49%
- 3Y*
- 76.58%
- 5Y*
- 40.10%
- 10Y*
- 46.35%
ANAB
- 1D
- 1.97%
- 1M
- -25.92%
- YTD
- 58.91%
- 6M
- 73.08%
- 1Y
- 225.06%
- 3Y*
- 60.31%
- 5Y*
- 26.26%
- 10Y*
- —
LRCX vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LRCX Lam Research Corporation | 89.76% | 139.16% | -6.84% | 88.63% | -40.72% | 53.66% | 64.18% | 119.33% | -24.40% | 62.95% |
ANAB AnaptysBio, Inc. | 58.91% | 266.16% | -38.19% | -30.88% | -10.82% | 61.63% | 32.31% | -74.53% | -36.67% | 492.47% |
Correlation
The correlation between LRCX and ANAB is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jan 27, 2017 | 0.23 |
Fundamentals
LRCX:
$409.71B
ANAB:
$1.47B
LRCX:
$5.29
ANAB:
-$0.91
LRCX:
18.98
ANAB:
6.51
LRCX:
38.71
ANAB:
115.60
LRCX:
$21.68B
ANAB:
$232.39M
LRCX:
$10.84B
ANAB:
$245.59M
LRCX:
$6.10B
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LRCX vs. ANAB — Risk / Return Rank
LRCX
ANAB
LRCX vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lam Research Corporation (LRCX) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LRCX | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.16 | ||
| Sortino ratioReturn per unit of downside risk | +0.84 | ||
| Omega ratioGain probability vs. loss probability | 1.60 | 1.49 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 14.02 | 8.05 | +5.97 |
| Martin ratioReturn relative to average drawdown | 47.19 | 20.07 | +27.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LRCX | ANAB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 5.46 | 3.29 | +2.16 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.87 | 0.40 | +0.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.04 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.23 | +0.20 |
Drawdowns
LRCX vs. ANAB - Drawdown Comparison
The maximum LRCX drawdown since its inception was -87.90%, roughly equal to the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for LRCX and ANAB.
Loading charts...
Drawdown Indicators
| LRCX | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.90% | -92.08% | +4.18% |
Max Drawdown (1Y)Largest decline over 1 year | -20.01% | -28.15% | +8.14% |
Max Drawdown (3Y)Largest decline over 3 years | -47.10% | -69.32% | +22.22% |
Max Drawdown (5Y)Largest decline over 5 years | -56.39% | -69.32% | +12.93% |
Max Drawdown (10Y)Largest decline over 10 years | -56.39% | — | — |
Current DrawdownCurrent decline from peak | -5.60% | -40.07% | +34.47% |
Average DrawdownAverage peak-to-trough decline | -28.18% | -64.71% | +36.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.93% | 11.27% | -5.34% |
Volatility
LRCX vs. ANAB - Volatility Comparison
Lam Research Corporation (LRCX) has a higher volatility of 18.51% compared to AnaptysBio, Inc. (ANAB) at 12.10%. This indicates that LRCX's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LRCX | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.51% | 12.10% | +6.41% |
Volatility (6M)Calculated over the trailing 6-month period | 42.13% | 46.22% | -4.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.52% | 68.91% | -17.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.25% | 65.30% | -19.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.76% | 75.47% | -30.71% |
Dividends
LRCX vs. ANAB - Dividend Comparison
LRCX's dividend yield for the trailing twelve months is around 0.31%, while ANAB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANAB AnaptysBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LRCX Lam Research Corporation | 0.31% | 0.57% | 1.19% | 0.95% | 1.53% | 0.78% | 1.04% | 1.54% | 2.79% | 1.01% | 1.28% | 1.36% |
Financials
LRCX vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between Lam Research Corporation and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LRCX and ANAB have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LRCX has higher volatility (18.51%) compared to ANAB (12.10%). In terms of maximum drawdown, LRCX dropped -87.90% vs ANAB's -92.08%.
LRCX currently has the higher Sharpe Ratio (5.46 vs 3.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LRCX and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer